Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13,

Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter 
and Full Year 2013 Financial Results on March 13, 2014 
DEERFIELD, IL -- (Marketwired) -- 02/27/14 --   Horizon Pharma, Inc.
(NASDAQ: HZNP) announced today that its fourth quarter and year ended
December 31, 2013 financial results will be released on Thursday,
March 13, 2014. Following the announcement, Horizon's management will
host a live conference call and webcast at 8:00 am Eastern Time to
review the Company's financial and operating results and provide a
general business update.  
The live webcast and a replay may be accessed by visiting Horizon's
website at http://ir.horizon-pharma.com. Please connect to the
Company's website at least 15 minutes prior to the live webcast to
ensure adequate time for any software download that may be needed to
access the webcast. Alternatively, please call 1-888-338-8373 (U.S.)
or 973-872-3000 (international) to listen to the conference call. The
conference ID number for the live call is 58632547. Telephone replay
will be available approximately two hours after the call. To access
the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406
(international). The conference ID number for the replay is 58632547. 
About Horizon Pharma
 Horizon Pharma, Inc. is a commercial stage,
specialty pharmaceutical company that markets DUEXIS(R),
RAYOS(R)/LODOTRA(R) and VIMOVO(R), which target unmet therapeutic
needs in arthritis, pain and inflammatory diseases. The Company's
strategy is to develop, acquire or in-license additional innovative
medicines or companies where it can execute a targeted commercial
approach among specific target physicians such as primary care
physicians, orthopedic surgeons and rheumatologists, while taking
advantage of its commercial strengths and the infrastructure the
Company has put in place. For more information, please visit
www.horizonpharma.com. 
Contacts:
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
investor-relations@horizonpharma.com 
 
 
Press spacebar to pause and continue. Press esc to stop.